法国儿童中耐大环内酯类化脓性链球菌菌株的出现。
Emergence of macrolide-resistant Streptococcus pyogenes strains in French children.
作者信息
Bingen Edouard, Bidet Philippe, Mihaila-Amrouche Liliana, Doit Catherine, Forcet Samuel, Brahimi Naïma, Bouvet Anne, Cohen Robert
机构信息
Université Denis Diderot-Paris 7, Service de Microbiologie, Hôpital Robert Debré, 48 Bd Sérurier, 75019 Paris, France.
出版信息
Antimicrob Agents Chemother. 2004 Sep;48(9):3559-62. doi: 10.1128/AAC.48.9.3559-3562.2004.
Abstract
We studied the antimicrobial susceptibility of 322 Streptococcus pyogenes throat isolates from French children and their serotype and genomic diversity. A total of 22.4% were erythromycin resistant, and 69.4, 4.2, and 26.4% of these isolates harbored ermB, ermA, and mefA, respectively. Increasing resistance in France is mainly associated with a few emm type 28 clones.
摘要
我们研究了来自法国儿童的322株化脓性链球菌咽喉分离株的抗菌药敏性及其血清型和基因组多样性。共有22.4%的分离株对红霉素耐药，其中分别有69.4%、4.2%和26.4%的分离株携带ermB、ermA和mefA。法国耐药性增加主要与少数emm28型克隆有关。
相似文献
1
Emergence of macrolide-resistant Streptococcus pyogenes strains in French children.
Antimicrob Agents Chemother. 2004 Sep;48(9):3559-62. doi: 10.1128/AAC.48.9.3559-3562.2004.
2
Decline in macrolide-resistant Streptococcus pyogenes isolates from French children.
Int J Med Microbiol. 2012 Dec;302(7-8):300-3. doi: 10.1016/j.ijmm.2012.09.001. Epub 2012 Oct 25.
3
High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China.
Pediatr Pulmonol. 2009 May;44(5):436-41. doi: 10.1002/ppul.20976.
4
Prevalence of macrolide resistance in Streptococcus pyogenes collected in Serbia.
Jpn J Infect Dis. 2010 Jul;63(4):275-6.
5
Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
Clin Infect Dis. 2005 Sep 1;41(5):599-608. doi: 10.1086/432473.
6
Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types.
Diagn Microbiol Infect Dis. 2009 Jul;64(3):295-9. doi: 10.1016/j.diagmicrobio.2009.03.004. Epub 2009 Apr 22.
7
Macrolide-resistant genes of Streptococcus pyogenes isolated from the upper respiratory tract by polymerase chain reaction.
J Infect Chemother. 2004 Apr;10(2):115-20. doi: 10.1007/s10156-004-0302-x.
8
Macrolide resistance in group A beta haemolytic Streptococcus isolated from outpatient children in Latvia.
APMIS. 2010 May;118(5):366-70. doi: 10.1111/j.1600-0463.2010.02607.x.
9
Distribution of subclasses mefA and mefE of the mefA gene among clinical isolates of macrolide-resistant (M-phenotype) Streptococcus pneumoniae, viridans group streptococci, and Streptococcus pyogenes.
Antimicrob Agents Chemother. 2005 Feb;49(2):827-9. doi: 10.1128/AAC.49.2.827-829.2005.
10
Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA.
J Antimicrob Chemother. 2006 Jun;57(6):1240-3. doi: 10.1093/jac/dkl101. Epub 2006 Mar 23.
引用本文的文献
1
Antibiotics in Food Chain: The Consequences for Antibiotic Resistance.
Antibiotics (Basel). 2020 Oct 13;9(10):688. doi: 10.3390/antibiotics9100688.
2
emm Types and clusters and macrolide resistance of pediatric group A streptococcal isolates in Central Greece during 2011-2017.
PLoS One. 2020 May 7;15(5):e0232777. doi: 10.1371/journal.pone.0232777. eCollection 2020.
3
High Prevalence of Macrolide-resistance and Molecular Characterization of Isolates Circulating in China from 2009 to 2016.
Front Microbiol. 2017 Jun 8;8:1052. doi: 10.3389/fmicb.2017.01052. eCollection 2017.
4
Throat Carriage Rate and Antimicrobial Resistance of In Rural Children in Argentina.
J Prev Med Public Health. 2017 Mar;50(2):127-132. doi: 10.3961/jpmph.15.073. Epub 2017 Jan 4.
5
Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in Turkey.
J Antimicrob Chemother. 2016 May;71 Suppl 1(Suppl 1):i71-83. doi: 10.1093/jac/dkw075.
6
Antibiotic Susceptibility Evaluation of Group A Streptococcus Isolated from Children with Pharyngitis: A Study from Iran.
Infect Chemother. 2015 Dec;47(4):225-30. doi: 10.3947/ic.2015.47.4.225. Epub 2015 Dec 30.
7
Molecular Basis for Erythromycin Resistance in Group A Streptococcus Isolated From Skin and Soft Tissue Infections.
J Clin Diagn Res. 2015 Nov;9(11):DC21-3. doi: 10.7860/JCDR/2015/14744.6843. Epub 2015 Nov 1.
8
Decline in macrolide resistance rates among Streptococcus pyogenes causing pharyngitis in children isolated in Italy.
Eur J Clin Microbiol Infect Dis. 2015 Sep;34(9):1797-802. doi: 10.1007/s10096-015-2414-x. Epub 2015 May 30.
9
Increased prevalence of group A streptococcus isolates in streptococcal toxic shock syndrome cases in Japan from 2010 to 2012.
Epidemiol Infect. 2015 Mar;143(4):864-72. doi: 10.1017/S0950268814001265.
10
Disease manifestations and pathogenic mechanisms of Group A Streptococcus.
Clin Microbiol Rev. 2014 Apr;27(2):264-301. doi: 10.1128/CMR.00101-13.
本文引用的文献
1
Dissemination of emm28 erythromycin-, clindamycin- and bacitracin-resistant Streptococcus pyogenes in Spain.
Eur J Clin Microbiol Infect Dis. 2004 Feb;23(2):123-6. doi: 10.1007/s10096-003-1069-1. Epub 2004 Jan 8.
2
Activity of telithromycin compared with seven other agents against 1039 Streptococcus pyogenes pediatric isolates from ten centers in central and eastern Europe.
Clin Microbiol Infect. 2003 Jul;9(7):741-5. doi: 10.1046/j.1469-0691.2003.00598.x.
3
Emergence of macrolide resistance in throat culture isolates of group a streptococci in Ontario, Canada, in 2001.
Antimicrob Agents Chemother. 2003 Jul;47(7):2370-2. doi: 10.1128/AAC.47.7.2370-2372.2003.
4
Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000.
J Antimicrob Chemother. 2002 Sep;50 Suppl S1:9-24. doi: 10.1093/jac/dkf811.
5
Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh.
N Engl J Med. 2002 Apr 18;346(16):1200-6. doi: 10.1056/NEJMoa013169.
6
Emergence of group A streptococcus strains with different mechanisms of macrolide resistance.
Antimicrob Agents Chemother. 2002 May;46(5):1199-203. doi: 10.1128/AAC.46.5.1199-1203.2002.
7
In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999.
Clin Microbiol Infect. 2001 Jul;7(7):362-6. doi: 10.1046/j.1198-743x.2001.00280.x.
8
Phenotypic and genotypic characterization of macrolide-resistant group A Streptococcus strains in the province of Quebec, Canada.
J Antimicrob Chemother. 2001 Mar;47(3):345-8. doi: 10.1093/jac/47.3.345.
9
Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients.
Antimicrob Agents Chemother. 2000 Jun;44(6):1453-7. doi: 10.1128/AAC.44.6.1453-1457.2000.
10
Erythromycin resistance in Streptococcus pyogenes in Italy.
Emerg Infect Dis. 2000 Mar-Apr;6(2):180-3. doi: 10.3201/eid0602.000212.
Zotero 插件